Reports for UPJOHN CANADA ULC

Company Name

UPJOHN CANADA ULC

Totals

Shortage reports

61
Actual shortage: 7 (11%)
Anticipated shortage: 1 (2%)
Avoided shortage: 2 (3%)
Resolved: 51 (84%)

Discontinuation Reports

0
To be discontinued: 0
Discontinued: 0
Reversed: 0

Late reports

5 (8%)

Overdue reports

2 (25%)
Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
GD-ELETRIPTAN 40MG TABLET Resolved 2020-11-17 2021-02-04 128484
GD-LATANOPROST 50MCG SOLUTION Resolved 2022-03-15 2022-03-30 156728
GD-LATANOPROST/TIMOLOL 5MG 50MCG SOLUTION Resolved 2019-08-20 2019-09-18 91964
INSPRA 25MG TABLET Resolved 2017-07-20 2017-08-11 16559
INSPRA 25MG TABLET Resolved 2017-11-01 2018-04-17 27636
INSPRA 50MG TABLET Resolved 2018-03-07 2018-04-18 42162
INSPRA 50MG TABLET Resolved 2018-05-29 2018-07-20 50675
NEURONTIN 800MG TABLET Resolved 2022-09-01 2022-10-05 168396
NEURONTIN 600MG TABLET Resolved 2017-10-13 2018-02-01 25921
NEURONTIN 100MG CAPSULE Avoided shortage 2017-12-20 2018-02-07 33933
NEURONTIN 300MG CAPSULE Resolved 2017-12-20 2018-01-30 34010
NEURONTIN 400MG CAPSULE Resolved 2017-11-01 2018-02-08 27757
NITROSTAT 0.3MG TABLET Actual shortage 2022-11-02 2022-11-17 173311
NORVASC 10MG TABLET Resolved 2019-03-04 2020-01-18 77476
NORVASC 5MG TABLET Resolved 2018-06-13 2018-08-14 52370
RELPAX 40MG TABLET Resolved 2019-07-31 2019-12-20 90386
REVATIO 20MG TABLET Resolved 2017-03-13 2017-03-18 2036
REVATIO 0.8MG SOLUTION Resolved 2018-10-10 2018-12-18 63649
REVATIO 0.8MG SOLUTION Resolved 2020-04-03 2020-08-07 110817
REVATIO 0.8MG SOLUTION Resolved 2020-11-11 2021-01-21 128257

Showing 21 to 40 of 61

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 1 to 0 of 0